SEC Filing Summary: Astro-Med, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Astro-Med, Inc. on March 19, 2013. The report serves to disclose unaudited financial information regarding the Company's fourth quarter and twelve-month consolidated earnings. The specific financial data is contained within a press release dated March 19, 2013, attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being disclosed in the attached press release (Exhibit 99.1) but are not detailed within the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It only confirms the issuance of a press release containing the relevant earnings data.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. It explicitly states that the information in the attached press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 19, 2013) for actual revenue, earnings, and cash flow figures.
- Verify the unaudited nature of the financial data presented in the press release.
- Confirm the Company's legal name is Astro-Med, Inc., noting the discrepancy with the request metadata which listed "Astronova, Inc."
- Check for any subsequent filings that may incorporate the press release data by reference.